We are live on
!
Find out more
ADAP
Adaptimmune Therapeutics
ADAP
ADAP
Delisted
ADAP was delisted on the 27th of October, 2025.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 101 |
AAMU
101
Amundi Asset Management US
Boston,
Massachusetts
| – | -$43.5K | -5,900 | -100% |
|
| 102 |
SPIA
102
Steward Partners Investment Advisory
New York
| – | -$27K | -2,000 | Closed |
|
| 103 |
CAG
103
Csenge Advisory Group
Clearwater,
Florida
| – | -$5K | -1,003 | Closed |
|
| 104 |
MYIA
104
Mount Yale Investment Advisors
Denver,
Colorado
| – | -$6K | -833 | Closed |
|
| 105 |
SMFS
105
Squar Milner Financial Services
Irvine,
California
| – | -$9K | -645 | Closed |
|
| 106 |
TRCT
106
Tower Research Capital (TRC)
New York
| – | -$7K | -496 | Closed |
|
| 107 |
LYV
107
Live Your Vision
West Conshohocken,
Pennsylvania
| – | +$487 | +66 | New |
|